Where does ElevateBio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ElevateBio's 2 recorded funding rounds.

Premier Alternatives

ElevateBio

Discovery Tools (Healthcare)

ElevateBio is a private discovery tools (healthcare) company. It has raised $926 million across 2 recorded rounds; the latest was a $401 million Series D in May 2023.

PMV mark · valuation

—

Oct 2026

Priced at

—

Total raised

$926.0M

Last round

Later Stage VC (Series D)

May 2023

Cap table — not yet on record

ElevateBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on ElevateBio

·36 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about ElevateBio

Where does ElevateBio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ElevateBio's 2 recorded funding rounds.